Akira I. Hida

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

Zuzana Kos, Elvire Roblin, Rim S. Kim et al. · npj Breast Cancer · 2020 · 206 citations · Full text

Medicine, Oncology, Pathology +16

Clinicopathologic analysis of IgG4-related skin disease

Yasuharu Sato, Mai Takeuchi, Katsuyoshi Takata et al. · Modern Pathology · 2012 · 88 citations · Full text

Medicine, Dermatology, Pathology +14

Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies

Akira I. Hida, Yasuaki Sagara, Daisuke Yotsumoto et al. · Breast Cancer Research and Treatment · 2016 · 64 citations · Full text

Medicine, Immunology, Oncology +17

Correlation between 18F-FDG uptake on PET/MRI and the level of tumor-infiltrating lymphocytes (TILs) in triple-negative and HER2-positive breast cancer

Wakana Murakami, Mitsuhiro Tozaki, Michiro Sasaki et al. · European Journal of Radiology · 2019 · 50 citations

Medicine, Nuclear Medicine, Oncology +12

Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer

Akira I. Hida, Takahiro Watanabe, Yasuaki Sagara et al. · Breast Cancer Research and Treatment · 2019 · 44 citations

Medicine, Immunology, Oncology +12